Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Zvi Steinberg who wrote (808)	5/13/1998 12:04:00 PM
From: Zvi Steinberg	Read Replies (1) \| Respond to of 1491

Pharmos, as we all probably know by now, is presenting at the Alex Brown Healthcare Conference tomorrow Thursday. It is very important and tough to be invited to these conferences, and particularly to present your company. Pharmos will be in front of Alex Brown's institutional clients and money managers at this conference. This could be the first major coverage by a wall street firm. Business Week had an article about Dexanabinol a couple of years ago or so, in which Pharmos was mentioned by name. It was suggested to Pharmos that they follow up with the author of that article as we get closer to the unblinding of HU211. It will be nice to get good results from the study and good PR from Business Week. BOL will announce their co-marketing partner for Alrex prior to their sales conference the week of May 18. It will be interesting if Pharmos will make this known Thursday at the Alex brown conference...